(MDA) MDA - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA55292X1087
MDA: Space, Robotics, Satellites, Systems, Components, Intelligence
MDA Space Ltd., operating under the ticker symbol MDA on the Toronto Stock Exchange (TO), is a cornerstone of the space technology industry. With a market capitalization of CAD 2,689.10M and a price-to-earnings ratio of 40.59, the company is positioned as a high-growth player in the aerospace and defense sector. Founded in 1969 and headquartered in Brampton, Canada, MDA has evolved into a global leader in space robotics, satellite systems, and geointelligence solutions.
The companys core offerings include autonomous robotics and vision sensors designed for operation in space and on celestial bodies like the Moon and Mars. MDA also provides advanced robotic systems, ground control stations, and electro-optic sensors. Their product portfolio extends to satellite systems and sub-systems for communication networks, including low Earth orbit (LEO) constellations such as O3b mPower, Iridium Next, and OneWeb. This positions MDA as a critical enabler of space-based broadband internet and IoT connectivity.
MDAs geointelligence solutions leverage satellite-generated imagery and analytic services to deliver actionable insights in areas such as national security, climate change monitoring, and maritime surveillance. The company owns and operates the commercial data distribution for RADARSAT-2, a high-resolution synthetic aperture radar (SAR) satellite, and distributes optical imagery, satellite-based Automatic Identification System (AIS) data, and radio-frequency data from third-party missions. This makes MDA a key player in the global geospatial intelligence market.
From a financial perspective, MDAs forward P/E ratio of 22.12 suggests expectations of strong future earnings growth. The companys price-to-book ratio of 2.36 and price-to-sales ratio of 3.12 indicate a premium valuation, reflecting its market leadership and growth prospects. MDA serves a diverse client base, including government agencies, prime contractors, and space companies, providing a stable revenue stream across its global operations.
Investors should note that MDAs success is tied to its ability to innovate in high-cost, high-risk environments. The companys R&D investments are significant, and its growth trajectory depends on securing large-scale contracts, particularly in the competitive LEO constellation market. Additionally, geopolitical tensions
Additional Sources for MDA Stock
MDA Stock Overview
Market Cap in USD | 2,069m |
Sector | Industrials |
Industry | Aerospace & Defense |
GiC Sub-Industry | Aerospace & Defense |
IPO / Inception |
MDA Stock Ratings
Growth Rating | 44.1 |
Fundamental | 62.1 |
Dividend Rating | 0.0 |
Rel. Strength | 39.4 |
Analysts | - |
Fair Price Momentum | 26.47 CAD |
Fair Price DCF | 116.91 CAD |
MDA Dividends
No Dividends PaidMDA Growth Ratios
Growth Correlation 3m | 13.3% |
Growth Correlation 12m | 84.5% |
Growth Correlation 5y | 30.5% |
CAGR 5y | 14.43% |
CAGR/Max DD 5y | 0.21 |
Sharpe Ratio 12m | 0.00 |
Alpha | 70.43 |
Beta | 0.086 |
Volatility | 95.60% |
Current Volume | 213.6k |
Average Volume 20d | 469.7k |
As of April 13, 2025, the stock is trading at CAD 25.01 with a total of 213,616 shares traded.
Over the past week, the price has changed by +4.12%, over one month by -10.39%, over three months by -10.23% and over the past year by +68.08%.
Yes, based on ValueRay Fundamental Analyses, MDA (TO:MDA) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 62.05 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MDA as of April 2025 is 26.47. This means that MDA is currently overvalued and has a potential downside of 5.84%.
MDA has no consensus analysts rating.
According to ValueRays Forecast Model, MDA MDA will be worth about 28.6 in April 2026. The stock is currently trading at 25.01. This means that the stock has a potential upside of +14.31%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 34.9 | 39.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 28.6 | 14.3% |